Trial to Evaluate the Safety and Effectiveness of Vagus Nerve Stimulation for Children With Refractory Epilepsy

NCT03062514 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 84

Last updated 2018-01-02

No results posted yet for this study

Summary

Children with refractory epilepsy who are candidates for a treatment with vagus nerve stimulation will be prospectively randomized into 2 arms. Vagus nerve stimulation parameters are programmed and adjusted during outpatient clinic visits, within the normal clinical practice.

Conditions

  • Refractory Epilepsy

Interventions

DEVICE

PINS Vagus Nerve Stimualtor

PINS Vagus Nerve Stimualtor

Sponsors & Collaborators

  • Beijing Pins Medical Co., Ltd

    lead INDUSTRY

Principal Investigators

  • Yuwu Jiang, MD · Peking University First Hospital

  • Liping Zou · Chinese PLA General Hospital

  • Jianxiang Liao · Shenzhen Children's Hospital

  • Qian Chen · Children's Hospital of The Capital Institute of Pediatrics

  • Baomin Li · Qilu Hospital of Shandong University

  • Yuxing Gao · Shandong Provincial Hospital

  • Jianmin Liang · The First Hospital of Jilin University

  • Shaoping Huang · Second Affiliated Hospital of Xi'an Jiaotong University

  • Fei Yin · Xiangya Hospital of Central South University

  • Feng Gao · The Children's Hospital of Zhejiang University School of Medicine

  • Yanhui Chen · Fujian Medical University Union Hospital

  • XiaoMei SHU · Zunyi Medical College

  • Hua Yu · Shengjing Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
3 Years
Max Age
6 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-10-09
Primary Completion
2018-07-31
Completion
2019-12-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03062514 on ClinicalTrials.gov